Skip to content

Brain Works

Facebook
Twitter
LinkedIn
Ariana Gatt talks about pharma, fruit fly research, and Alzheimer’s and Parkinson’s disease.
Ariana Gatt
Ariana Gatt

In 2008 I graduated from the University of Malta with a B.Sc. in Chemistry and Biology. Then, I worked as an R&D chemist with SoleaPharma Ltd., which also allowed me to spend six months training in pharmaceutical chemistry in Spain at the mother company Gadea Pharmaceuticals. I learned a lot in this period—not only lab work skills, but also about the whole business and industry. However, after two years working in the pharma industry, I realised I still wanted to further my studies.

I had always dreamed of studying abroad and experiencing a university in another country, so I applied for Masters courses in the UK. I had realised by this point that I wanted to carry out biomedical research, with a particular interest in neuroscience. I read for an M.Sc. in molecular sciences and biomedical research at King’s College London, funded by an EU funded STEPS scholarship. The M.Sc. opened the door for a Ph.D. in the same lab, which I am currently finishing .

For my Ph.D., I am investigating the role of mitochondrial dysfunction in neurodegeneration. Mitochondria produce energy for our cells. They are especially important in brain cells, since the brain uses 20% of the body’s energy. In neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, mitochondria stop functioning properly, leading to a loss of energy in the brain. This may contribute to the eventual death of brain cells. In my project, I am modelling the loss of mitochondrial function in fruit flies (Drosophila melanogaster) to understand the early stages of neurodegeneration. Fruit flies and humans share many genes and therefore, studying the genes involved in mitochondrial dysfunction in the fly allows us to find potential early treatments to prevent irreparable damage in human neurodegenerative diseases. 

Part of my Ph.D. focuses on studying human tissue from patients who have died from these diseases. These post-mortem tissue samples are obtained from UK brain banks. I am using them to identify genes that are involved in these diseases. 

I don’t know what lies ahead in my career path. I hope it will involve answering questions regarding brain function and helping to solve the many puzzles related to neurodegenerative disease. 

Author

More to Explore

I Will Continue to Follow the Ship

Curated by Elyse Tonna with artist Dr Matthew Attard, ‘The Ship (Unseen)’ delivers the same brilliance and deep artistic intent which Attard, Tonna, and the rest of the team had been praised for during the 60th Venice Biennale. In 2025, the two sought to continue building on the themes of connection, identity, and memory established in ‘I Will Follow the Ship’, making use once again of that iconic, ever-moving, web-like linework.

AMBER: Stretching the Boundaries of Sustainable Rubber

Think about the rubber parts in your car, your shoes, or your household appliances. Traditionally, making rubber is an incredibly energy-intensive process that relies on ‘vulcanisation’ – a method that uses high temperatures and produces harmful emissions to make the material durable. But what if high-performance rubber could be eco-friendly and 3D-printed on demand?

Islam and Dance – A Contradiction?

When you think about Islam, do you think about dance? When you think about dance, do you imagine it as a part of meditation? THINK speaks to Ziya Azazi, founder of Dervish in Progress, and Dr Paula Guzzanti Ferrer from the Department of Dance Studies to uncover the fascinating connection between dance and Islam.

Comments are closed for this article!